Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1998 1
1999 2
2000 2
2001 12
2002 4
2003 8
2004 3
2005 6
2006 3
2007 6
2008 8
2009 1
2010 3
2011 10
2012 6
2013 5
2014 2
2015 5
2016 6
2017 11
2018 7
2019 5
2020 4
2021 6
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

122 results
Results by year
Filters applied: . Clear all
Page 1
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells.
Mangiapane LR, Nicotra A, Turdo A, Gaggianesi M, Bianca P, Di Franco S, Sardina DS, Veschi V, Signore M, Beyes S, Fagnocchi L, Fiori ME, Bongiorno MR, Lo Iacono M, Pillitteri I, Ganduscio G, Gulotta G, Medema JP, Zippo A, Todaro M, De Maria R, Stassi G. Mangiapane LR, et al. Among authors: signore m. Gut. 2022 Jan;71(1):119-128. doi: 10.1136/gutjnl-2020-323553. Epub 2021 Jan 12. Gut. 2022. PMID: 33436496 Free PMC article.
Gut Mesenchymal Stromal Cells in Immunity.
Messina V, Buccione C, Marotta G, Ziccheddu G, Signore M, Mattia G, Puglisi R, Sacchetti B, Biancone L, Valtieri M. Messina V, et al. Among authors: signore m. Stem Cells Int. 2017;2017:8482326. doi: 10.1155/2017/8482326. Epub 2017 Feb 28. Stem Cells Int. 2017. PMID: 28337224 Free PMC article. Review.
Drug repurposing for the treatment of glioblastoma multiforme.
Abbruzzese C, Matteoni S, Signore M, Cardone L, Nath K, Glickson JD, Paggi MG. Abbruzzese C, et al. Among authors: signore m. J Exp Clin Cancer Res. 2017 Nov 28;36(1):169. doi: 10.1186/s13046-017-0642-x. J Exp Clin Cancer Res. 2017. PMID: 29179732 Free PMC article. Review.
Elesclomol-induced increase of mitochondrial reactive oxygen species impairs glioblastoma stem-like cell survival and tumor growth.
Buccarelli M, D'Alessandris QG, Matarrese P, Mollinari C, Signore M, Cappannini A, Martini M, D'Aliberti P, De Luca G, Pedini F, Boe A, Biffoni M, Pallini R, Ricci-Vitiani L. Buccarelli M, et al. Among authors: signore m. J Exp Clin Cancer Res. 2021 Jul 12;40(1):228. doi: 10.1186/s13046-021-02031-4. J Exp Clin Cancer Res. 2021. PMID: 34253243 Free PMC article.
Targeting apoptosis pathways in cancer stem cells.
Signore M, Ricci-Vitiani L, De Maria R. Signore M, et al. Cancer Lett. 2013 May 28;332(2):374-82. doi: 10.1016/j.canlet.2011.01.013. Epub 2011 Feb 10. Cancer Lett. 2013. PMID: 21315505 Review.
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B.
Musella M, Guarracino A, Manduca N, Galassi C, Ruggiero E, Potenza A, Maccafeo E, Manic G, Mattiello L, Soliman Abdel Rehim S, Signore M, Pietrosanto M, Helmer-Citterich M, Pallocca M, Fanciulli M, Bruno T, De Nicola F, Corleone G, Di Benedetto A, Ercolani C, Pescarmona E, Pizzuti L, Guidi F, Sperati F, Vitale S, Macchia D, Spada M, Schiavoni G, Mattei F, De Ninno A, Businaro L, Lucarini V, Bracci L, Aricò E, Ziccheddu G, Facchiano F, Rossi S, Sanchez M, Boe A, Biffoni M, De Maria R, Vitale I, Sistigu A. Musella M, et al. Among authors: signore m. Nat Immunol. 2022 Sep;23(9):1379-1392. doi: 10.1038/s41590-022-01290-3. Epub 2022 Aug 24. Nat Immunol. 2022. PMID: 36002648 Free PMC article.
Antibody Validation by Western Blotting.
Signore M, Manganelli V, Hodge A. Signore M, et al. Methods Mol Biol. 2017;1606:51-70. doi: 10.1007/978-1-4939-6990-6_4. Methods Mol Biol. 2017. PMID: 28501993
122 results